Skip to main content

Table 4 Economic burden and mortality rate of the three groups

From: Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital

 

Case (Â¥)

control 1 (¥)

control 2 (¥)

p1

p2

Mortality

6/49 (12%)

1/96 (1%)

1/96 (1%)

0.01

0.01

Total costs

78,900

64,078

17,551

0.05

0.00

examination costs

2923

2571

1062

0.59

0.00

Medical test costs

6329

4649

1389

0.03

0.00

Total drug costs

42,586

29,051

6560.5

0.03

0.00

Anti-infective drug costs

8907

4820

122

0.01

0.00

  1. NOTE. Categorical variables are no/total no (%), continuous variables are median, case is carbapenem-resistant E.coli (CREC) , control 1 indicates the carbapenem-susceptible E.coli (CSEC) group, and p1 indicates the p values for the comparison between carbapenem-resistant E.coli (CREC) and carbapenem-susceptible E.coli (CSEC). Control 2 indicates the no infection group, and p2 indicates the p values for the comparison between carbapenem-resistant E.coli (CREC) group and no infection group